Skip to search formSkip to main contentSkip to account menu

luxabendazole

Known as: methyl 5-(4-fluorophenylsulfonyloxy)benzimidazole-2-carbamate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzimidazolesCarbamates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Biochemical effects of luxabendazole onTrichinella spiralis
Biochemical changes produced by luxabendazole in muscle-stageTrichinella spiralis larvae consisted of a decrease in free glucose… 
2004
2004
Activity of luxabendazole against liver flukes, gastrointestinal roundworms, and lungworms in naturally infected sheep
The anthelmintic potential of luxabendazolc was investigated in sheep harboring mixed naturally acquired helminth infections… 
1998
1998
Pharmacokinetics of intravenous luxabendazole in rabbits: influence of the enterohepatic circulation
Luxabendazole (LBZ) is a new benzimidazole carbamate chemotherapeutic agent, which has proved to be very effective against adult… 
1997
1997
Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
OBJECTIVE To determine pharmacokinetics of luxabendazole after oral and i.v. administration to healthy sheep. ANIMALS 7… 
1996
1996
Bacterial mutagenic evaluation of Luxabendazole, a new broad spectrum anthelmintic, with the Salmonella typhimurium His- and the Escherichia coli Tryp- reversion tests.
Luxabendazole is a new benzimidazole carbamate chemotherapeutic agent, which has proved to be effective against adult and… 
Review
1994
Review
1994
Glutathione S-transferases as markers of salicylanilide resistance in isolates of Fasciola hepatica.
1994
1994
Effects of luxabendazole on the tegument of Fasciola hepatica
Abstract The effects in vivo of 5, 10, and 20 mg/kg of luxabendazole (LBZ) on the tegument of Fasciola hepatica have been… 
1992
1992
Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis.
1990
1990
Structural and functional characteristics of the tegument and intestinal wall in mature Fasciola hepatica after treatment with luxabendazole.
The structural and functional alterations affect mainly the intactness and normal functioning of the tegument and the intestinal… 
1989
1989
Efficacy of luxabendazole (Hoe 216V) susp. 5% in game animals infected with helminths
Ces examens coprologiques ont prouve une efficacite elevee du traitement par une dose unique de 10 mg Kg −1 de poids corporel de… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)